CD4 and HIV infectious disease: Differences between the TPV+ and TPV− groups did not reach statistical significance for age (p = 0.6573), male sex (95.8% vs. 93.7%; p > 0.9999), BMI; (p = 0.1320), FRS (p = 0.1404), statin treatment (p = 0.7275), plasma levels of D-dimer (p = 0.3029), LDL (p = 0.2972), HDL (p = 0.7596), or triglycerides (p = 0.2033), as well as the CMV co-infection status (p = 0.5227), duration of HIV infection (p = 0.2363), nadir CD4 counts (p = 0.7889), or the frequency of CD4+ T-cells (p = 0.2250).